Literature DB >> 24668416

miR-99a and -99b inhibit cervical cancer cell proliferation and invasion by targeting mTOR signaling pathway.

Li Wang1, Lihua Chang, Zhaorong Li, Qing Gao, Dongge Cai, Yingfang Tian, Lingxia Zeng, Mu Li.   

Abstract

MicroRNAs were demonstrated to play an important role in the regulation of gene expression. Here, we showed that miR-99a and -99b (miR-99a/b) were down-regulated in human cervical cancer patient tissues and were negatively related with lymphatic metastasis. In addition, overexpression of miR-99a/b inhibited cell growth and invasion, whereas suppression of miR-99a/b yielded the reverse phenotype. Dual luciferase report assay revealed that mTOR was identified as a novel target gene of both miR-99a and -99b. Altogether, these results suggested that miR-99a/b directly and negatively regulated mTOR expression in cervical cancer cells, and enforced the importance of miR-99a/b and their targets in the malignant phenotypes of cervical carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24668416     DOI: 10.1007/s12032-014-0934-3

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  24 in total

Review 1.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

2.  Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma.

Authors:  Zujian Chen; Yi Jin; Dongsheng Yu; Anxun Wang; Ishrat Mahjabeen; Cheng Wang; Xiqiang Liu; Xiaofeng Zhou
Journal:  Oral Oncol       Date:  2012-03-17       Impact factor: 5.337

3.  miRNA overexpression induces cardiomyocyte proliferation in vivo.

Authors:  Andrew H Baker; Eva van Rooij
Journal:  Mol Ther       Date:  2013-03       Impact factor: 11.454

4.  MiRNA-20a promotes osteogenic differentiation of human mesenchymal stem cells by co-regulating BMP signaling.

Authors:  Jin-fang Zhang; Wei-ming Fu; Ming-liang He; Wei-dong Xie; Qing Lv; Gang Wan; Guo Li; Hua Wang; Gang Lu; Xiang Hu; Su Jiang; Jian-na Li; Marie C M Lin; Ya-ou Zhang; Hsiang-fu Kung
Journal:  RNA Biol       Date:  2011-07-28       Impact factor: 4.652

5.  MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR).

Authors:  Dong Wu; Hui-juan Huang; Chun-ni He; Kai-yu Wang
Journal:  Int J Gynecol Cancer       Date:  2013-09       Impact factor: 3.437

6.  MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.

Authors:  Dong Li; Xingguang Liu; Li Lin; Jin Hou; Nan Li; Chunmei Wang; Pin Wang; Qian Zhang; Peng Zhang; Weiping Zhou; Zhengxin Wang; Guoshan Ding; Shi-Mei Zhuang; Limin Zheng; Wenzhao Tao; Xuetao Cao
Journal:  J Biol Chem       Date:  2011-08-30       Impact factor: 5.157

7.  microRNA-99b acts as a tumor suppressor in non-small cell lung cancer by directly targeting fibroblast growth factor receptor 3.

Authors:  Jaeku Kang; Soo Young Lee; Sun Young Lee; Young Jin Kim; Jae Yong Park; Sun Jung Kwon; Moon Jun Na; Eun Jin Lee; Hyo Sung Jeon; Ji Woong Son
Journal:  Exp Ther Med       Date:  2011-10-14       Impact factor: 2.447

8.  Activation of mTOR signaling pathway contributes to survival of cervical cancer cells.

Authors:  Jing Ji; Peng-Sheng Zheng
Journal:  Gynecol Oncol       Date:  2010-01-27       Impact factor: 5.482

9.  MIR-99a and MIR-99b modulate TGF-β induced epithelial to mesenchymal plasticity in normal murine mammary gland cells.

Authors:  Gianluca Turcatel; Nicole Rubin; Ahmed El-Hashash; David Warburton
Journal:  PLoS One       Date:  2012-01-27       Impact factor: 3.240

10.  Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma.

Authors:  Anna Torres; Kamil Torres; Anna Pesci; Marcello Ceccaroni; Tomasz Paszkowski; Paola Cassandrini; Giuseppe Zamboni; Ryszard Maciejewski
Journal:  BMC Cancer       Date:  2012-08-24       Impact factor: 4.430

View more
  32 in total

1.  Potential impact of mTOR inhibitors on cervical squamous cell carcinoma: A systematic review.

Authors:  Daniele Xavier Assad; Silvia Taveira Elias; Andréia Cristina Melo; Carlos Gil Ferreira; Graziela De Luca Canto; Eliete Neves Silva Guerra
Journal:  Oncol Lett       Date:  2016-09-20       Impact factor: 2.967

2.  A dual PI3K/AKT/mTOR signaling inhibitor miR-99a suppresses endometrial carcinoma.

Authors:  Yunyun Li; Zhongzu Zhang; Xiaojing Zhang; Ying Lin; Tangshu Luo; Zhenghua Xiao; Qin Zhou
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

3.  MicroRNA-320 suppresses cervical cancer cell viability, migration and invasion via directly targeting FOXM1.

Authors:  Can Shi; Zhenyu Zhang
Journal:  Oncol Lett       Date:  2017-07-21       Impact factor: 2.967

4.  Downregulation of CCR5 inhibits the proliferation and invasion of cervical cancer cells and is regulated by microRNA-107.

Authors:  Li-Fan Che; Su-Fang Shao; Li-Xin Wang
Journal:  Exp Ther Med       Date:  2015-12-04       Impact factor: 2.447

5.  Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.

Authors:  Min Luo; Dongxiang Shen; Wei Wang; Jiang Xian
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 6.  Emerging Role of MicroRNAs in mTOR Signaling.

Authors:  Yanjie Zhang; Bo Huang; Hui-Yun Wang; Augustus Chang; X F Steven Zheng
Journal:  Cell Mol Life Sci       Date:  2017-02-25       Impact factor: 9.261

7.  Down-regulated expression of miR-99a is associated with lymph node metastasis and predicts poor outcome in stage IB cervical squamous cell carcinoma: a case-control study.

Authors:  Gongyi Zhang; Rong Zhang; Ping Bai; Shumin Li; Jing Zuo; Yuanyuan Zhang; Mei Liu; Lingying Wu
Journal:  Ann Transl Med       Date:  2022-06

8.  miR-99a-5p inhibits glycolysis and induces cell apoptosis in cervical cancer by targeting RRAGD.

Authors:  Gang Wang; Yu Lu; Shi Di; Maohua Xie; Fang Jing; Xiaoyan Dai
Journal:  Oncol Lett       Date:  2022-05-27       Impact factor: 3.111

9.  Bioselection Reveals miR-99b and miR-485 as Enhancers of Adenoviral Oncolysis in Pancreatic Cancer.

Authors:  Maria Rovira-Rigau; Giulia Raimondi; Miguel Ángel Marín; Meritxell Gironella; Ramon Alemany; Cristina Fillat
Journal:  Mol Ther       Date:  2018-09-27       Impact factor: 11.454

10.  RNA sequencing reveals a depletion of collagen targeting microRNAs in Dupuytren's disease.

Authors:  Scott M Riester; Diren Arsoy; Emily T Camilleri; Amel Dudakovic; Christopher R Paradise; Jared M Evans; Jorge Torres-Mora; Marco Rizzo; Peter Kloen; Marianna Kruithof-de Julio; Andre J van Wijnen; Sanjeev Kakar
Journal:  BMC Med Genomics       Date:  2015-10-07       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.